Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -24.40% is 59% above its 5-year average of -59.08%, near the high end of its 5-year range (-98.84%–-23.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 58.26% above its 12-month average of -58.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -24.40%.
RETURN ON INVESTED CAPITAL (ROIC)
-24.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-58.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-73.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-59.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+58.26%
CURRENT VS 3Y AVG
+66.84%
CURRENT VS 5Y AVG
+58.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 732 covered companies
CURRENT VS SECTOR MEDIAN
+26.93%
vs the sector median at left
Rallybio Corporation
Market Cap
$89.38M
Return on Invested Capital (ROIC)
-24.40%
TTM Avg
-58.45%
3Y Avg
-73.57%
5Y Avg
-59.08%
Market Cap
$89.60M
Return on Invested Capital (ROIC)
-111.42%
TTM Avg
-65.09%
3Y Avg
-48.38%
5Y Avg
-36.92%
Market Cap
$89.70M
Return on Invested Capital (ROIC)
-216.05%
TTM Avg
-121.78%
3Y Avg
-79.31%
5Y Avg
-71.06%
Market Cap
$90.38M
Return on Invested Capital (ROIC)
-217.73%
TTM Avg
-143.58%
3Y Avg
-163.00%
5Y Avg
-133.51%
Market Cap
$90.47M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
Market Cap
$90.70M
Return on Invested Capital (ROIC)
-34.10%
TTM Avg
-61.58%
3Y Avg
-76.39%
5Y Avg
-65.18%
Market Cap
$86.90M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$86.47M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$92.54M
Return on Invested Capital (ROIC)
-220.02%
TTM Avg
-209.28%
3Y Avg
-141.42%
5Y Avg
-99.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rallybio Corporation (RLYB) | $89.38M | -24.40% | -58.45% | -73.57% | -59.08% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | -111.42% | -65.09% | -48.38% | -36.92% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.70M | -216.05% | -121.78% | -79.31% | -71.06% |
| electroCore, Inc. (ECOR)vs › | $90.38M | -217.73% | -143.58% | -163.00% | -133.51% |
| ImmuCell Corporation (ICCC)vs › | $90.47M | 8.16% | 0.11% | -4.79% | -3.69% |
| Equillium, Inc. (EQ)vs › | $90.70M | -34.10% | -61.58% | -76.39% | -65.18% |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 12.79% | 17.38% | -11.40% | -8.36% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.47M | -100.35% | -639.99% | -358.78% | -266.51% |
| Biomea Fusion, Inc. (BMEA)vs › | $92.54M | -220.02% | -209.28% | -141.42% | -99.57% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.57M | -109.43% | -208.02% | -178.83% | -203.50% |
ROIC
-24.4%
ROE
48.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -24.40% |
| 2026-03-31 | -55.88% |
| 2025-12-31 | -56.97% |
| 2025-09-30 | -60.59% |
| 2025-06-30 | -94.42% |
| 2025-03-31 | -93.17% |
| 2024-12-31 | -97.79% |
| 2024-09-30 | -98.84% |
| 2024-06-30 | -96.30% |
| 2024-03-31 | -90.00% |
| 2023-12-31 | -74.21% |
| 2023-09-30 | -60.51% |
| 2023-06-30 | -53.33% |
| 2023-03-31 | -46.26% |
| 2022-12-31 | -40.00% |
| 2022-09-30 | -47.67% |
| 2022-06-30 | -36.56% |
| 2022-03-31 | -28.82% |
| 2021-12-31 | -25.99% |
| 2021-09-30 | -23.28% |
| 2021-06-30 | -35.63% |
| 2021-03-31 | -27.81% |
| 2020-12-31 | -18.60% |
